Home/Filings/4/0001127602-22-006288
4//SEC Filing

Finke Daniel P 4

Accession 0001127602-22-006288

CIK 0000064803other

Filed

Feb 22, 7:00 PM ET

Accepted

Feb 23, 4:25 PM ET

Size

11.6 KB

Accession

0001127602-22-006288

Insider Transaction Report

Form 4
Period: 2022-02-21
Finke Daniel P
EVP/Pres, Health Care Benefits
Transactions
  • Award

    Common Stock

    2022-02-21+34,38757,713.961 total
Holdings
  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01Common Stock (54,332 underlying)
    54,332
  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01Common Stock (82,066 underlying)
    82,066
  • Common Stock (restricted)

    25,701
  • Common Stock (pep)

    3,097.808
  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01Common Stock (32,322 underlying)
    32,322
  • Stock Option

    Exercise: $52.37From: 2022-05-31Exp: 2029-05-31Common Stock (28,640 underlying)
    28,640
Footnotes (5)
  • [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's Aetna Inc. 2010 Incentive Compensation Plan (the "Aetna Plan") on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
  • [F2]Option became exercisable in four equal annual installments, beginning on 4/1/2020.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F4]Option becomes exercisable in four equal installments, commencing 4/1/2022.
  • [F5]Option becomes exercisable in three equal installments, commencing 5/31/2022.

Issuer

CVS HEALTH Corp

CIK 0000064803

Entity typeother

Related Parties

1
  • filerCIK 0001844305

Filing Metadata

Form type
4
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:25 PM ET
Size
11.6 KB